05/27/2026
A new update on NDI-5001 points to real progress in treatment research for X-linked congenital NDI. It is not an approved cure, and it is still early, but the latest milestone matters.
We’ve posted a short breakdown of what changed, who this first step applies to, and why families may want to stay connected as the research moves forward.
Read the update and subscribe to NDIF for future research news.
A possible treatment for X-linked congenital NDI is moving closer to human study. NDI-5001 is now part of a registered Phase 1b trial, giving families a meaningful sign of progress while research continues.